WFM
NPSP

Wilmington Funds Management’s NPS PHARMACEUTICALS INC NPSP Stock Holding History

Wilmington Funds Management’s Portfolio NPSP Stock Details NPSP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q2 		$345K Buy
10,432
+1,940
+23% +$56K 0.03% 478
2014
Q1 		$254K Hold
8,492
– – 0.03% 586
2013
Q4 		$258K Buy
+8,492
New +$234K 0.03% 605

Other funds holding NPSP

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
JHIU
Janus Henderson Investors US Denver, Colorado $122B AUM 18.26% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
ORI
Oak Ridge Investments Chicago, Illinois $1.77B AUM 63.16% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $303B AUM 30.15% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

Wilmington Funds Management's NPSP Position: Q2 2014 in Review

Wilmington Funds Management increased its NPS PHARMACEUTICALS INC (NPSP) stake by 23% in Q2 2014, buying an estimated $56K and bringing the position to 10,432 shares worth $345K. The position accounts for 0.03% of the portfolio, ranked #478.

Wilmington Funds Management first reported a position in NPSP in Q4 2013 and has held it in 3 quarters since. 215 funds tracked by Wall St. Rank hold NPSP as of Q2 2014.

  • Wilmington Funds Management held 10,432 shares of NPS PHARMACEUTICALS INC worth $345K as of Q2 2014.
  • Wilmington Funds Management bought 1,940 NPS PHARMACEUTICALS INC shares in Q2 2014, an estimated $56K.
  • NPS PHARMACEUTICALS INC made up 0.03% of Wilmington Funds Management's portfolio in Q2 2014, its #478 holding.
  • Wilmington Funds Management first reported a position in NPS PHARMACEUTICALS INC in Q4 2013 and has held it in 3 quarters since.
  • 215 funds tracked by Wall St. Rank held NPS PHARMACEUTICALS INC as of Q2 2014.

Based on Wilmington Funds Management's 13F filing for Q2 2014, filed 13 Aug 2014.